1. Mesenchymal stromal cells in myeloid malignancies: Immunotherapeutic opportunities
   Milica Vukotić et al, 2024, Heliyon CrossRef
2. Germline Predisposition to Hematopoietic Malignancies: An Overview
   Yogameenakshi Haribabu et al, 2024, Annual Review of Cancer Biology CrossRef
3. Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
   Suncica Kapor et al, 2021, Journal of Clinical Medicine CrossRef
4. Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy
   Suncica Kapor et al, 2024, Acta Histochemica CrossRef
5. Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience
   Hui-Lin Chin et al, 2023, Frontiers in Oncology CrossRef
6. ETS variant transcription factor 6 enhances oxidized low-density lipoprotein-induced inflammatory response in atherosclerotic macrophages via activating NF-κB signaling
   Xiaofang Xiong et al, 2022, International Journal of Immunopathology and Pharmacology CrossRef
7. Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment
   Fabiana Kalina Marques et al, 2022, Biomedicine & Pharmacotherapy CrossRef